CrushSCI.com
提供学术论文选刊润色服务
Drug Metabolism and Pharmacokinetics 期刊封面 医学
返回期刊列表

Review Cycle Records

Drug Metabolism and Pharmacokinetics

Elsevier SCIE 非OA
2026新锐 4区2025中科院 4区2025 JCR Q3
109.2平均天数
104中位天数
44最短天数
186最长天数
4592025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

119 天

Characterization of unusual pyrazole ring-rearranged metabolites of DS-1971a specific to monkeys

作者Daigo Asano; Kazuyoshi Michiba; Kayoko Masuda; Takashi Ohnuki; Makoto Suzuki; Tetsuya Suzuki; Hideyuki Shiozawa; Tsuyoshi Shinozuka; Toshio Takatsu; Daisuke Nakai

作者单位Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Modality Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Modality Research Laboratories II, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Discovery Science and Technology Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan; Analytical & Quality Evaluation Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Corporate Planning Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Center for Pharmaceutical and Biomedical Analysis, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan

PDF源文件 DOI 网页
93 天

Development of a method for vancomycin monitoring in interstitial fluid using a novel porous microneedle array patch

作者Jo Terauchi; Taisei Kawamura; Jongho Park; Kiyomi Saito; Masataka Tajima; Hitoshi Sato; Beomjoon Kim; Erika Sugiyama

作者单位Department of Pharmacokinetics and Pharmacodynamics, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan; Department of Precision Engineering, School of Engineering, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8656, Japan; Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo, 153-8505, Japan; Innovation Center for Cannabinoid Research, Faculty of Pharmacy, Mahidol University, Bangkok, 10400, Thailand

PDF源文件 DOI 网页
63 天

Development and validation of LC–MS-based bioanalytical methods for oligonucleotide therapeutics: points to consider

作者Yuchen Sun; Kosuke Saito; Shin-ichiro Nitta; Ryoya Goda; Yuki Kishino; Hisashi Fujita; Masaaki Kakehi; Yoshiharu Hayashi; Satoshi Ito; Tomomi Ishida; Kiyomi Kikuchi; Kazuko Inoue; Kazutaka Shimbo; Takeru Yamaguchi; Fumihiro Jinno; Kaori Murakoshi; Chie Murata; Kentaro Takahara; Mitsuhiko Kawabata; Ruri Kikura-Hanajiri; Yoshiro Saito

作者单位Division of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa, 210-9501, Japan; Mediford Corporation, 1-15-10 Shimura, Itabashi-ku, Tokyo, 174-0056, Japan; Future Peak Co., Ltd., 3-48 Imainakamachi, Nakahara-ku, Kawasaki City, Kanagawa, 211-0065, Japan; Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan; Takeda Pharmaceutical Co., Ltd., 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-8555, Japan; CMIC Pharma Science Co., Ltd., 17-18 Nakahatacho, Nishiwaki City, Hyogo, 677-0032, Japan; Sekisui Medical Co., Ltd., 2117 Muramatsu, Tokai-mura naka-gun, Ibaraki, 319-1182, Japan; Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki, 300-2635, Japan; Ajinomoto Co., Inc., 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki City, Kanagawa, 210-8681, Japan; Sumika Chemical Analysis Service, Ltd., 3-1-135 Kasugadenaka, Konohana-ku, Osaka City, Osaka, 554-0022, Japan; Axcelead Drug Discovery Partners, Inc., 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-0012, Japan; Tanabe Pharma Corporation, 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-8555, Japan; Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamotocho, Mishima-gun, Osaka, 618-8585, Japan; Thermo Fisher Scientific K.K., 3-9 Moriyacho, Kanagawa-ku, Yokohama City, Kanagawa, 221-0022, Japan; Shin Nippon Biomedical Laboratories Ltd., 16-1 Minamiakasaka, Kainan-city, Wakayama, 642-0017, Japan; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa, 210-9501, Japan

PDF源文件 DOI 网页
168 天

A permeability assay adapted for the assessment of very poorly permeable compounds in the bRo5 space

作者Paulina Page; Dallas Bednarczyk

作者单位Pharmacokinetic Sciences, Novartis Institutes of BioMedical Science, Cambridge, MA, USA

PDF源文件 DOI 网页
124 天

A novel scaling approach for human pharmacokinetic prediction of antibody-drug conjugates using minimal nonclinical data: Integration of monkey PK and in vitro data

作者Satoshi Nakayama; Nao Torimoto; Toshiyuki Kudo; Kiyomi Ito

作者单位DMPK Research Laboratories, Research Division, Tanabe Pharma Corporation, 1000, Kamoshida-cho Aoba-ku, Yokohama-shi, Kanagawa, 227-0033, Japan; Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo, 202-8585, Japan

PDF源文件 DOI 网页
44 天

K2-EDTA anticoagulant suppresses calcium-dependent paraoxonase 1-mediated hydrolysis in human plasma stability assays

作者Lloyd Wei Tat Tang

作者单位Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, CT, USA

PDF源文件 DOI 网页
105 天

Role of the arachnoid mater organic anion and cation transporters in the clearance of prostaglandin D2 and metformin from the cerebrospinal fluid in rats

作者Yuka Yaguchi; Kazunari Sasaki; Mai Inagaki; Tetsuya Terasaki; Masanori Tachikawa

作者单位Graduate School of Pharmaceutical Sciences, Tokushima University, 1-78-1 Sho-machi, Tokushima, 770-8505, Japan; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8578, Japan; Graduate School of Biomedical Sciences, Tokushima University, 1-78-1 Sho-machi, Tokushima, 770-8505, Japan; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, 70210, Finland; Institute of Photonics and Human Health Frontier, Tokushima University, 2-24, Shinkura-cho, Tokushima, 770-8501, Japan

PDF源文件 DOI 网页
87 天

Differences in reactive metabolite formation and cytochrome P450 binding between acetaminophen and its bicyclo[1.1.1]pentane bioisostere

作者Minami Shibata; Ayato Mizuno; Tomoki Nakayoshi; Akifumi Oda; Masaya Nakajima; Masanobu Uchiyama; Masahiro Hiratsuka; Yoshihiro Yamanishi; Kouichi Yoshinari

作者单位Laboratory of Molecular Toxicology, Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan; Laboratory of Biophysical Chemistry, Graduate School of Pharmacy, Meijo University, Nagoya, Japan; Institute for Advanced Research, Nagoya University, Nagoya, Japan; Advanced Elements Chemistry Laboratory, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan; Laboratory of Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; Department of Complex Systems Science, Graduate School of Informatics, Nagoya University, Nagoya, Japan; Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

PDF源文件 DOI 网页
103 天

Physiologically-based pharmacokinetic modeling of coproporphyrin I, an endogenous OATP1B substrate, in cynomolgus monkeys: Bridging the inhibitory effect of rifampicin to humans

作者Takashi Yoshikado; Yukana Tomoda; Kouki Kasai; Reiki Toda; Satofumi Iida; Koji Chiba

作者单位Laboratory of Clinical Pharmacology, Yokohama University of Pharmacy, 601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, 245-0066, Japan

PDF源文件 DOI 网页
186 天

Microfluidic post-insertion preparation and evaluation of RGD- and PEG-modified macrophage-derived small extracellular vesicles

作者Mizuki Umino; Longjian Geng; Yusuke Ushiroda; Makoto Matsumoto; Hidefumi Mukai; Shigeru Kawakami

作者单位School of Pharmaceutical Sciences, Nagasaki University, 1-14 Bunkyo, Nagasaki-shi, Nagasaki, 852-8521, Japan; Department of Pharmaceutical Informatics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, 852-8588, Japan; Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, 852-8588, Japan

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。